Provided by Tiger Trade Technology Pte. Ltd.

Chemours

13.83
-0.1500-1.07%
Pre-market: 13.940.1100+0.80%08:29 EDT
Volume:2.72M
Turnover:37.77M
Market Cap:2.07B
PE:-6.85
High:14.15
Open:13.88
Low:13.72
Close:13.98
52wk High:28.67
52wk Low:10.44
Shares:149.89M
Float Shares:148.93M
Volume Ratio:1.33
T/O Rate:1.83%
Dividend:0.35
Dividend Rate:2.53%
EPS(TTM):-2.0200
EPS(LYR):-2.5700
ROE:-319.37%
ROA:1.42%
PB:-42.31
PE(LYR):-5.38

Loading ...

Chemours Q1 FY26 net loss widens to $29 million; net sales rise 1% to $1.4 billion

Reuters
·
May 06

Chemours Q1 revenue slightly beats estimates

Reuters
·
May 06

Chemours Q1 Adj. EPS $0.05 Beats $(0.05) Estimate, Sales $1.381B Miss $1.387B Estimate

Benzinga Earnings
·
May 06

BRIEF-Chemours Q1 Adjusted EPS USD 0.05 Vs. IBES Estimate USD -0.05

Reuters
·
May 06

Chemours Outlook Q2 Consolidated Net Sales to Increase in Range of 15% to 20%

THOMSON REUTERS
·
May 06

Chemours Q1 Adjusted Ebitda USD 169 Million VS. Ibes Estimate USD 138.1 Million

THOMSON REUTERS
·
May 06

Chemours Q1 Sales USD 1,400 Million VS. Ibes Estimate USD 1,387 Million

THOMSON REUTERS
·
May 06

Chemours Q1 Adjusted EPS USD 0.05 VS. Ibes Estimate USD -0.05

THOMSON REUTERS
·
May 06

Chemours Q1 EPS USD 0.19

THOMSON REUTERS
·
May 06

the Chemours Company Reports First Quarter Results

THOMSON REUTERS
·
May 06

Chemours options imply 11.8% move in share price post-earnings

TIPRANKS
·
May 06

The ultimate superannuation EOFY checklist 2026

Morning Star AU
·
May 06

Press Release: Facephi Ends 2025 with Solid Performance Across All Key Metrics: Double-Digit Revenue and Tripple-Digit EBITDA Growth. It Returns to Profitability

Dow Jones
·
May 04

Chemours shareholders approve 2026 equity and incentive plan at annual meeting

Reuters
·
Apr 30

AstraZeneca Flexes Cancer Drugs Performance, Pipeline Strength

Benzinga Earnings
·
Apr 29

Earning Preview: Chemours Q1 revenue is expected to increase by 2.56%, and institutional views are cautious

Earnings Agent
·
Apr 28

Chemours Is Maintained at Buy by Truist Securities

Dow Jones
·
Apr 28

Chemours updates financial calendar for first-quarter earnings release and conference call

Reuters
·
Apr 22

Insignia Financial Suspended from ASX as CC Capital-Backed BidCo Takes Over

TIPRANKS
·
Apr 17

Insignia Financial Secures Federal Court Approval for CC Capital Takeover

MT Newswires Live
·
Apr 16